Luis Anibarro-García (Luis Anibarro)

ResearcherID Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 9

Top Topics

Pulmonary Tuberculosis

Clinical Practice

Mild Traumatic Brain Injury

Acinetobacter Baumannii

Top Venues

Tropical medicine and infectious disease

Patient preference and adherence

This page only lists publications with an associated author ORCID identifier.

Publications

Kai Ling Chin, Luis Anibarro-García, Maria E Sarmiento, Armando Acosta
Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection. Tropical medicine and infectious disease 8 (2) (2023)
Kai Ling Chin, Luis Anibarro-García, Maria E Sarmiento, Armando Acosta
Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection. Tropical medicine and infectious disease 8 (2) (2023)
Sandra Pérez-Recio, Maria D Grijota-Camino, Luis Anibarro-García, Ramón Rabuñal-Rey, Josefina Sabria, Paloma Gijón-Vidaurreta, Virginia Pomar, Mercedes García-Gasalla, Ángel Domínguez-Castellano, Matilde Trigo, María Jesús Santos, Alba Cebollero, Sara Rodríguez, Esther Moga, Anton Penas-Truque, Carmen Martos, M Jesús Ruiz-Serrano, Erika I Garcia-de-Cara, Fernando Alcaide, Miguel Santin
Reversions of QuantiFERON-TB Gold Plus in tuberculosis contact investigation: A prospective multicentre cohort study. PloS one 18 (8) (2023)
Kai Ling Chin, Luis Anibarro-García, Maria E Sarmiento, Armando Acosta
Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection. Tropical medicine and infectious disease 8 (2) (2023)
Kai Ling Chin, Luis Anibarro-García, Maria E Sarmiento, Armando Acosta
Challenges and the Way forward in Diagnosis and Treatment of Tuberculosis Infection. Tropical medicine and infectious disease 8 (2) (2023)
Miguel Santin, Sandra Perez-Recio, Maria D Grijota, Luis Anibarro-García, Jose M Barcala, Maria L De Souza-Galvao, Paloma Gijon, Rafael Luque, Francesca Sanchez, null null
Comparison of three short-course rifamycin-based regimens for the prevention of tuberculosis in patients with end-stage kidney disease: Study protocol for a randomised clinical trial (RIFAKiD-TB trial). PloS one 17 (10) (2022)
Ana Rodríguez-Regal, Laura Ramos-Rúa, Luis Anibarro-García, Ana María Lopez Real, María Del Campo Amigo-Jorrín
Effectiveness of Dimethyl Fumarate in Real-World Clinical Practice and Strategy to Minimize Adverse Effects and Use of Healthcare Resources. Patient preference and adherence 15 (2021)
Olivia Estévez, Luis Anibarro-García, Elina Garet, Ángeles Pallares, Alberto Pena, Carlos Villaverde, Víctor Del Campo, África González-Fernández
Identification of candidate host serum and saliva biomarkers for a better diagnosis of active and latent tuberculosis infection. PloS one 15 (7) (2020)
Luis Anibarro-García, Eliana Cortés, Ana Chouza, Alberto Parafita-Fernández, Juan Carlos García, Alberto Pena, Carlos Fernández-Cid, África González-Fernández
Early treatment of tuberculous uveitis improves visual outcome: a 10-year cohort study. Infection 46 (4) (2018)